Strata Critical Medical Posts 9-Cent Q3 Loss Per Share
SRTA is trading near its 52-week low of $3.95 (8.9% above the low) on elevated volume (2.5× avg).
Summary
Strata Critical Medical reported a third-quarter loss of 9 cents per share on revenue of $74.1M, and reiterated its 2026 guidance. The company also announced a buyback. The loss lands while Third Point holds a 5.8% activist stake and is pressing the company to explore strategic alternatives, which raises the stakes on any sign of margin or cash deterioration. A trust tied to former board member Eric L. Affeldt also filed in October to sell 100,000 shares, adding supply overhang.
At the time of this announcement, SRTA was trading at $4.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $378.6M. The 52-week trading range was $3.95 to $6.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.